King of Prussia, PA, United States of America

Roderick S Davis

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovations of Roderick S. Davis

Introduction

Roderick S. Davis, an accomplished inventor based in King of Prussia, Pennsylvania, has made significant contributions to the field of pharmaceutical research. With a focus on innovative compounds that serve as NRF2 activators and regulators, Davis has successfully secured two patents that reflect his commitment to advancing medical science.

Latest Patents

Davis’s latest patents include groundbreaking inventions related to bisaryl heterocycles. His first patent, titled "Bisaryl heterocycles as NRF2 activators," outlines compounds, methods for creating them, and pharmaceutical compositions that leverage their NRF2 activation properties. Additionally, he has developed another patent focusing on "Nrf2 regulators," which comprises aryl analogs, their pharmaceutical compositions, and uses that enhance NRF2 regulation in therapeutic settings.

Career Highlights

Roderick S. Davis has built a remarkable career at prominent companies in the pharmaceutical sector. He has notably worked with GlaxoSmithKline Intellectual Property Development Limited, where his expertise in patent development was applied to various innovative projects. Moreover, his tenure at Astex Therapeutics Limited allowed him to contribute to cutting-edge research and drug development initiatives.

Collaborations

Throughout his career, Davis has collaborated with distinguished colleagues, including Jeffrey K. Kerns and James Francis Callahan. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields, further emphasizing the impact of teamwork in scientific research.

Conclusion

Roderick S. Davis stands as a testament to the spirit of innovation, with his contributions to NRF2 activators and regulators paving the way for new therapeutic possibilities. His work underscores the importance of intellectual property in fostering advancements in healthcare, making him a notable figure within the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…